HIV/AIDS Vaccines
Studies from Uniformed Services University of the Health Sciences add new findings in the area of HIV/AIDS vaccines
Published in Vaccine Weekly, July 11th, 2007
Researchers detail in "Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization," new data in HIV/AIDS. According to recent research from the United States, "An immunization regimen was evaluated in rabbits consisting of the soluble, oligomeric form of envelope glycoprotein of HIV-1, strain R2 (gp140(R2)), or the surface component of the same envelope (Env), gp120(R2), in the adjuvant AS02A. The gp140(R2) was selected based on its unusual CD4-independent phenotype and the exceptionally broad neutralizing response in the infected donor."
"The gp140(R2) immunogen induced antibodies that achieved 50% neutralization of 48/48, and 80%...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-07-11)
More Articles from Vaccine Weekly
- HIV/AIDS Co-Infection
New Vaccine Prevents CMV Infection and Disease in Mice - Autism
Vaccinated Children Two and a Half Times More Likely to Have Neurological Disorders Like ADHD and Autism, New Survey in California and Oregon Finds - Bird Flu
Carrington Subsidiary DelSite Predicts Preservative-Free Vaccines in World's Future - Cancer Vaccines
Bacilligen, Inc. Receives Investment from Maryland Department of Business and Economic Development Challenge Investment Program - Cancer Vaccines
Immunotope, Inc. Receives Second Investment from Ben Franklin Technology Partners of Southeastern PA - Cancer Vaccines
Largest Cervical Cancer Vaccine Efficacy Trial Shows CERVARIX Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
